Korean Registry of Percutaneous EVAR With INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)

Prospective single-arm multicenter registry

Inclusion criteria

• 1. AAA with one of following indications

• AAA with maximum diameter > 5 cm,
• AAA with maximum diameter > 4 cm with an increase >0.5 cm during the preceding 6 months
• Saccular type AAA irrespective of the sac diameter.
• 2. Proximal aortic neck length ≥10 mm with a diameter ≥ 17 and ≤ 31 mm in combination with supra- and infrarenal angulation ≤ 60 degree.
• 3. Iliac landing zone with a length ≥15 mm and a diameter ≥ 7 and ≤ 22 mm
• 4. Femoral access vessels should be adequate to fit the selected delivery system
• 5. Minimum overall AAA treatment length (proximal landing location to distal landing location to distal landing location) ≥128 mm
• 6. Aortic bifurcation >18 mm in diameter
• 7. Patents with age of 19-80 years.
• 8. Male or non-pregnant female
• 9. Voluntary participation in the study with signed informed consent form.

Exclusion criteria

• 1. Dissecting or ruptured abdominal aortic aneurysm
• 2. Presence of connective tissue disease (Marfan's syndrome or Ehlers-Danlos syndrome).
• 3. Prior AAA or iliac artery repair
• 4. Active infection or active vasculitis.
• 5. Myocardial infarction or cerebrovascular accident within 3 months prior to study enrolment.
• 6. Need for renal artery coverage (e.g. Chimney graft)
• 7. Dialysis-dependent renal failure or serum creatinine >2.0 mg/dl
• 8. Intolerance/hypersensitivity to contrast media or antiplatelet drugs.
• 9. Positive pregnancy test.
• 10. Participation in another medical research study within 1 month of study enrolment.
• 11. Planned concomitant surgical procedures (other than left subclavian artery transposition or bypass) or major surgery within 30 days of study enrolment.
• 12. Patients with life expectancy less than 1 year